[ad_1]
It has been almost two years since the Covid-19 pandemic broke out around the world. Why Doctor provides an update on the latest information on the virus.
The epidemic is starting again in Europe, the WHO is concerned
In France, the incidence rate increased for third consecutive week between October 28 and November 4. On average, 6,000 new cases are detected per day. Hospitalization rates are increasing further in three French regions: Pays de la Loire, Provence-Alpes-Côte d’Azur and Bourgogne-Franche-Comté. According to the WHO, the rates of hospitalizations linked to Covid-19 have more than doubled in a week in Europe and Central Asia. For Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, the old continent and Central Asia are again the epicenter of the global epidemic. He estimates there could be 500,000 more deaths from the disease by February 2022 if nothing is done. To avoid them, he encourages countries to continue to vaccinate their populations and to maintain barrier measures such as the wearing a maskroom ventilation and physical distancing.
Europe & Central Asia again at pandemic epicenter
Testing, contact tracing, ventilation & physical distancing are part of our arsenal of #COVID19 defenses, next to the rapid, fair & broad uptake of vaccines by everyone eligible.
My statement in full ????https://t.co/ZrMG6BSLrm pic.twitter.com/KbNsdzSLHO
— Hans Kluge (@hans_kluge) November 4, 2021
Pfizergate: what are we talking about?
On the vaccine side, Pfizer’s serum has been implicated in a study published in the British Medical Journal, Tuesday, November 2. According to its authors, one of the subcontractors of the Pfizer laboratory committed negligence in the scientific protocol at the time of the clinical tests. Among the shortcomings reported by the medical journal, there is in particular a lack of follow-up of patients after the injection, unreported protocol deviations, poor labeling of certain samples or even storage of vaccines at inappropriate temperatures. . If the revelations are disturbing, France Info recalls that they concern only 2.3% of the total of the tests carried out by Pfizer. According to Thibault Fiolet, epidemiologist at Inserm, interviewed by the information site, “the small proportion of sites and participants concerned does not call into question the results of the efficacy of the tests of the Pfizer vaccine. The Pfizer laboratory and the Ventavia company have announced that they are investigating these accusations. This did not stop the United States in its campaign to vaccination : the country began vaccinating children aged 5 to 11 on Wednesday, November 3.
Authorized treatment in the UK
On Thursday November 4, the United Kingdom announced the authorization of the monulpiravir in the country. This red tablet can be used against Covid-19 in people suffering from a mild to moderate form of the disease, and having a risk factor for a severe form (diabetes for example). The treatment makes it possible to limit the replication of the virus in the organism. To act, it must be taken at the earliest. According to the Merck laboratory, which created it, it could reduce the risk of hospitalization by 50%. The drug is currently being evaluated by US and European health authorities. For its part, the United Kingdom has already ordered 480,000 treatments of monulpiravir.
[ad_2]
Source link
